A New Jersey appeals court has overturned two verdicts totaling $83 million in suits against Johnson & Johnson and C.R. Bard over alleged defects in the companies’ vaginal mesh products.

In separate trials before two judges, evidentiary rulings wrongly excluded evidence that the companies’ products received a designation known as Section 510(K) clearance from the Food and Drug Administration, the appeals court said.